Manufacturers Life Insurance Company, The Novo Cure LTD Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Novo Cure LTD stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 202,027 shares of NVCR stock, worth $3.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

202,027

Previous 187,772 7.59%

Holding current value

$3.58 Million

Previous $3.22 Million 1.83%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.61 - $23.34 $222,520 - $332,711	14,255 Added 7.59%	202,027 $3.16 Million
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $448,960 - $912,721	37,951 Added 25.33%	187,772 $3.22 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $360,602 - $501,997	29,034 Added 24.04%	149,821 $2.34 Million
Q4 2023 Feb 13, 2024	BUY	$11.13 - $15.78 $262,768 - $372,550	23,609 Added 24.29%	120,787 $1.8 Million
Q3 2023 Nov 15, 2023	BUY	$16.15 - $42.35 $109,432 - $286,963	6,776 Added 7.5%	97,178 $1.57 Million
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $669,337 - $1.37 Million	16,613 Added 22.51%	90,402 $3.75 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $779,210 - $1.64 Million	13,806 Added 18.71%	87,595 $5.27 Million
Q4 2022 Aug 11, 2023	SELL	$63.98 - $85.37 $190,276 - $253,890	-2,974 Reduced 3.87%	73,789 $5.41 Million
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $190,276 - $253,890	-2,974 Reduced 3.87%	73,789 $5.41 Million
Q3 2022 Aug 11, 2023	BUY	$67.99 - $89.57 $364,494 - $480,184	5,361 Added 7.51%	76,763 $5.83 Million
Q3 2022 Nov 03, 2022	BUY	$67.99 - $89.57 $364,494 - $480,184	5,361 Added 7.51%	76,763 $5.91 Million
Q2 2022 Aug 11, 2023	BUY	$56.6 - $89.9 $891,619 - $1.42 Million	15,753 Added 28.31%	71,402 $4.96 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $935,428 - $1.49 Million	16,527 Added 30.12%	71,402 $5.17 Million
Q1 2022 Aug 11, 2023	SELL	$60.15 - $84.52 $1.92 Million - $2.7 Million	-31,946 Reduced 36.47%	55,649 $4.61 Million
Q1 2022 Aug 15, 2022	BUY	$60.15 - $84.52 $3.3 Million - $4.64 Million	54,875 New	54,875 $4.61 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $1.74 Million - $2.92 Million	-15,014 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $5,737 - $9,925	44 Added 0.29%	15,014 $3.33 Million
Q1 2021 May 03, 2021	SELL	$124.11 - $190.17 $16,010 - $24,531	-129 Reduced 0.85%	14,970 $1.98 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $54,397 - $84,457	485 Added 3.32%	15,099 $2.61 Million
Q2 2020 Aug 10, 2020	SELL	$57.2 - $74.41 $3.01 Million - $3.92 Million	-52,631 Reduced 78.27%	14,614 $1.15 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $171,834 - $288,399	3,012 Added 4.69%	67,245 $4.53 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $67,685 - $92,955	-991 Reduced 1.52%	64,233 $5.8 Million
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $692,893 - $1.1 Million	11,201 Added 20.73%	65,224 $4.79 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $338,519 - $506,978	8,018 Added 17.43%	54,023 $3.42 Million
Q1 2019 May 13, 2019	SELL	$31.96 - $56.12 $576,782 - $1.01 Million	-18,047 Reduced 28.18%	46,005 $2.22 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $1.33 Million - $2.43 Million	-46,234 Reduced 41.92%	64,052 $2.15 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $1.82 Million - $2.99 Million	56,995 Added 106.95%	110,286 $5.78 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $176,268 - $284,160	8,880 Added 20.0%	53,291 $1.67 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $13,683 - $16,767	-709 Reduced 1.57%	44,411 $968,000
Q4 2017 Feb 08, 2018	BUY	$16.3 - $21.9 $2,282 - $3,066	140 Added 0.31%	45,120 $911,000
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $811,889 - $978,315	44,980	44,980 $892,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Novo Cure LTD Transaction History